Transanální minimalne invazivní resekce rekta s totalni mezorektalni excizí po endoskopické mukóznf resekci

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Transanal minimally invasive rectal resection with total mesorectal excision after endoscopic mucosal resection
Authors

KUNOVSKÝ Lumír KALA Zdeněk SVATOŇ Roman DASTYCH Milan KROUPA Radek DOLINA Jiří ČAN Vladimír PROCHÁZKA Vladimír

Year of publication 2017
Type Article in Periodical
Magazine / Source Gastroenterologie a hepatologie
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.14735/amgh2017208
Field Surgery incl. transplantology
Keywords Endoscopic mucosal resection; Rectal cancer; Rectal surgery; Total mesorectal excision; Transanal minimally invasive surgery
Description Rectal cancer constitutes a serious oncological problem, and treatment of this disease involves a multidisciplinary team. Nowadays, rectal cancer constitutes more than a quarter of newly diagnosed colorectal cancers in the Czech Republic. Almost 70% of colorectal cancers develop from adenomatous polyps. Benign lesions such as adenoma or hyperplastic polyps can be treated endoscopically. In addition, in non-invasive malignant lesions (which are limited to the mucosa), endoscopic resection is considered curative. If certain criteria are met, endoscopic local excision can be considered a fully curative procedure, even in invasive cancer (cut-off limit: submucosa layer SM2). In patients with an unfavourable tumour grade, with carcinoma invading the submucosal layer (SM3), the cancer cannot be treated endoscopically by endoscopic mucosal resection (EMR) or endoscopic submucosal dissection and surgery is indicated. In some cases, endoscopic treatment can be inadequate and a surgical procedure has to be performed. During 2014-2015, four patients in our department underwent EMR to treat flat mucosal lesions 4-8 cm from the anal verge; however, local excision was not oncologically radical enough, and the patients were indicated for surgical resection. In these patients, a rectal resection with coloanal anastomosis was performed by transanal minimally invasive surgery (TAMIS), a new method that combines mini-invasive surgery with radical surgery resection without a permanent stoma, while meeting oncological radicality criteria. TAMIS can be beneficially used in patients after EMR if histology is promptly evaluated. Total mesorectal excision (TME), i.e., the removal of the fat coating surrounding the rectum along with its lymphatic nodes, has already become a standard surgical treatment for rectal cancer. TAMIS can be used for rectal resection with TME without the need for a stoma, even in low rectal cancer. Adverse histological results after EMR do not necessarily need to lead to an indication for rectal resection with a permanent stoma, but there is a possibility of intersphincteric resection with total lymphadenectomy.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.